These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 39366109)

  • 1. Exploring intranasal drug delivery via nanocarriers: A promising glioblastoma therapy.
    Deshmukh V; Pathan NS; Haldar N; Nalawade S; Narwade M; Gajbhiye KR; Gajbhiye V
    Colloids Surf B Biointerfaces; 2024 Sep; 245():114285. PubMed ID: 39366109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.
    Agosti E; Zeppieri M; Antonietti S; Battaglia L; Ius T; Gagliano C; Fontanella MM; Panciani PP
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Nose to Brain Nano Delivery for Effective Management of Migraine.
    Tanna V; Sawarkar SP; Ravikumar P
    Curr Drug Deliv; 2023; 20(2):144-157. PubMed ID: 35366772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery.
    Maher R; Moreno-Borrallo A; Jindal D; Mai BT; Ruiz-Hernandez E; Harkin A
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review.
    Babu SR; Shekara HH; Sahoo AK; Harsha Vardhan PV; Thiruppathi N; Venkatesh MP
    Ther Deliv; 2023 Sep; 14(9):571-594. PubMed ID: 37691577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions.
    Kumar N; Khurana B; Arora D
    Pharm Dev Technol; 2023 Dec; 28(10):1032-1047. PubMed ID: 37975846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management.
    Upadhaya PG; Pulakkat S; Patravale VB
    Drug Deliv Transl Res; 2020 Aug; 10(4):1044-1056. PubMed ID: 32221847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review.
    Kapoor A; Hafeez A; Kushwaha P
    Curr Drug Deliv; 2024; 21(5):709-725. PubMed ID: 37365787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal delivery of neurotherapeutics
    Rajput A; Pingale P; Dhapte-Pawar V
    Front Pharmacol; 2022; 13():979682. PubMed ID: 36176429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
    Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
    Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nose to brain delivery in rats: Effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization.
    Bonaccorso A; Musumeci T; Serapide MF; Pellitteri R; Uchegbu IF; Puglisi G
    Colloids Surf B Biointerfaces; 2017 Jun; 154():297-306. PubMed ID: 28363190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy.
    Wong CYJ; Baldelli A; Hoyos CM; Tietz O; Ong HX; Traini D
    Drug Deliv Transl Res; 2024 Jul; 14(7):1776-1793. PubMed ID: 38441832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson's disease treatment?
    Rehman S; Nabi B; Zafar A; Baboota S; Ali J
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1355-1366. PubMed ID: 31663382
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
    Jain D; Rashid MA; Ahmad FJ
    Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders.
    Awad R; Avital A; Sosnik A
    Acta Pharm Sin B; 2023 May; 13(5):1866-1886. PubMed ID: 37250152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature.
    Alotaibi BS; Buabeid M; Ibrahim NA; Kharaba ZJ; Ijaz M; Noreen S; Murtaza G
    Int J Nanomedicine; 2021; 16():7517-7533. PubMed ID: 34795481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.